Acquired von Willebrand syndrome associated with a smoldering multiple myeloma, successfully treated by daratumumab, lenalidomide and dexamethasone
CONCLUSION: Daratumumab, lenalidomide, and dexamethasone demonstrated as a rapid and effective treatment for a patient with severe AvWS and multiple bleeding complications.PMID:38359808 | DOI:10.1159/000536650
Source: Acta Haematologica - Category: Hematology Authors: Michael Iarossi Marie-Christiane Madeleine Vekemans Nicolas Weynants Cedric Hermans Source Type: research
More News: Bleeding | Dexamethasone | Hematology | Myeloma | Myeloproliferative Disorders | Pathology | Revlimid | von Willebrand Disease